COVID-19 and flu vaccinations now available to everyone
Ontario expanded access Oct. 26, following earlier vaccination of higher-risk and priority groups.

COVID-19 and flu vaccinations are now available to everyone in Russell Township and The Nation.
Ontario expanded access Oct. 26 to everyone six months and older who lives, works or attends school in the province. Both vaccines are free. Higher-risk and priority groups had earlier access. Ontario vaccination information
The Eastern Ontario Health Unit says flu, COVID-19 and respiratory syncytial virus, or RSV, are circulating in the community.
“Compared to previous years, the flu has started making its rounds earlier than usual,” said Dr. Paul Roumeliotis, the health unit’s medical officer of health, in an Oct. 20 announcement.
The health unit particularly encourages vaccination for young children, older adults, pregnant people and those with chronic conditions or weakened immune systems. People living with or caring for someone at higher risk are also encouraged to get immunized. EOHU announcement
Where to go locally
Ontario’s vaccine locator lists both flu and COVID-19 vaccinations at these pharmacies. Call before travelling to confirm vaccine supply, appointment or walk-in arrangements and age requirements.
Russell
- Russell Pharmacy: 110 Craig St., 613-445-5555.
- Downtown Pharmacy: 1106 Concession St., 613-445-1223.
Embrun
- Embrun Compounding Pharmacy: 934 Notre Dame St., 613-443-2999.
- Embrun Pharmasave: 829 Notre Dame St., 343-456-3669.
- Embrun Remedy’sRx: 753 Notre Dame St., 613-443-2357.
- Jean Coutu: 867 Notre Dame St., 613-443-3552.
- Notre Dame Pharmacy: 649 Notre Dame St., Unit 104, 613-443-4444.
- Shoppers Drug Mart: 703 Notre Dame St., 613-443-3669.
The Nation
- Limoges Guardian Pharmacy: 601 Limoges Rd., Unit 1, Limoges, 613-443-2525.
- Pharmacie St-Isidore: 4512 Ste-Catherine St., St-Isidore, 613-524-9795.
The Ontario vaccine locator provides participating pharmacy details. A listing does not guarantee that a dose or appointment is immediately available.
Appointments for young children
Pharmacies provide flu shots to children aged two and older. Parents seeking COVID-19 vaccination for young children should check with the pharmacy because service for children six months to four years varies by location. Ontario pharmacy information
Children six months to under five and their household members can also receive flu and COVID-19 vaccinations by appointment through the EOHU.
Families can use the health unit’s online booking system or call 613-933-1375 or 1-800-267-7120. Anyone unable to obtain a flu shot through a pharmacy or healthcare provider can also contact the health unit for help. EOHU booking information
RSV protection is also available
The EOHU says publicly funded RSV vaccination is available to people aged 75 and older, and to eligible people aged 60 to 74 who are at higher risk or live in higher-risk settings. Residents can ask their healthcare provider or the health unit about eligibility and where to receive it. The pharmacy list above confirms flu and COVID-19 services, not publicly funded RSV vaccination. EOHU information
How much COVID is circulating?
The latest accessible Public Health Ontario report covers Oct. 11 to 17. It records three COVID-19 cases in the EOHU area, with 1.6 per cent of tests positive. Across Ontario, 277 cases were recorded and test positivity was 3.4 per cent.
There was one new hospital admission involving a COVID-positive patient at a hospital in the EOHU area that week, compared with 87 across Ontario.
Those figures require care. They do not count every infection, and a positive hospital test does not necessarily mean COVID caused the admission. Hospital figures are assigned according to the hospital’s location rather than the patient’s home address. Testing practices and reporting delays also affect the numbers. PHO dashboard · Technical notes
The region’s reported death toll
Public Health Ontario’s EOHU surveillance series records 350 COVID-19 deaths from the beginning of the pandemic through Oct. 17, 2026.
Ten were recorded between Oct. 29, 2024 and Oct. 17, 2026, covering nearly the past two years. The latest available figures do not yet cover Oct. 18 to 28.
These are reported surveillance totals rather than a complete death-registration tally. PHO excludes deaths clearly unrelated to COVID and cases still under review, and the figures can change as reporting is completed. PHO outcomes data and definitions
Which variants are circulating?
There is not enough recent local sequencing evidence to identify a dominant COVID variant in Russell Township or the EOHU area.
The latest Ontario genomic report located for this story was dated Oct. 5 and covered 231 sequenced cases collected between Aug. 23 and Sept. 19. The leading individual lineages were PJ.2.1 at 13 per cent, TA.1 at 12.1 per cent and SB.1.1 at 9.1 per cent.
Only two samples in that report came from Ontario’s broader eastern region. That is too few to establish which variant predominates locally, and the September results should not be read as an October snapshot. PHO genomic report
What this year’s COVID vaccines target
The available 2026–27 COVID vaccines target the Omicron XFG variant. Ontario’s offerings include Moderna’s Spikevax for people six months and older, Pfizer’s Comirnaty for ages 12 and older, and the protein-based Nuvaxovid for ages 12 and older at participating pharmacies.
Not every pharmacy necessarily carries every product. Anyone seeking a particular vaccine should ask when booking. PHAC vaccine guide · Ontario product information from Toronto Public Health
Different names among circulating variants do not automatically mean the vaccine is poorly matched. TA.1 and SB.1.1 are descendants of XFG, while PJ.2.1 belongs to another branch. Their family relationships alone do not establish how effectively vaccine-generated immunity will recognize them. PHO variant genealogy
An early study of 22 people given Pfizer’s XFG vaccine found increased neutralizing antibodies against the variants tested, including PJ.2.1. But the research was a small laboratory study published before peer review. It did not measure how many infections or hospitalizations the vaccine prevented, and it did not test Nuvaxovid.
The World Health Organization was still requesting variant-specific evidence on Oct. 27 for its December review of vaccine composition. The evidence supports continued monitoring, rather than a conclusion that different variant names mean vaccination has stopped working. Original research · WHO evidence request
A COVID vaccine that is not mRNA
Nuvaxovid is the vaccine developed by Novavax, a company based in Maryland. Sanofi became its Canadian market-authorization holder this year, which explains why it appears in Canadian information as Sanofi Nuvaxovid. Novavax · Sanofi announcement
It contains no mRNA. Instead, it delivers an already-made coronavirus spike protein that the immune system can learn to recognize.
To produce it, cultured insect cells are used to make the spike protein through recombinant biotechnology. The protein is then purified and combined with Matrix-M, an ingredient that strengthens the immune response. This season’s version uses the XFG spike protein.
Pfizer and Moderna’s mRNA vaccines work differently: they provide temporary instructions that allow the recipient’s cells to make the spike protein. Nuvaxovid supplies the protein itself. It does not contain live coronavirus.
That gives eligible people a non-mRNA option, but the different technology does not by itself establish that one product is better or more suitable for a particular person. A pharmacist or healthcare provider can discuss the available choices. Canadian Nuvaxovid product information
Does an early flu season mean a severe one?
An early start does not yet establish how severe the entire winter will be.
For Oct. 11 to 17, Ontario’s flu test positivity was 3.5 per cent. PHO described activity as low but projected an increase through Oct. 31. It also reported that, despite the early start, flu activity was increasing more gradually than in the previous four seasons, without evidence yet of a faster climb toward a peak.
The EOHU area recorded 12 flu cases and two new hospital admissions involving flu-positive patients that week, with test positivity of 6.7 per cent. As with COVID, those are surveillance measurements rather than a complete count of infections.
PHO’s short-term model projected rising combined hospitalization risk from flu, COVID and RSV across age groups. That is a two-week outlook for several viruses together, not a prediction that this winter’s flu season will be unusually severe.
